Header Logo

Connection

Elizabeth Bayliss to Breast Neoplasms

This is a "connection" page, showing publications Elizabeth Bayliss has written about Breast Neoplasms.
Connection Strength

0.075
  1. Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial. Ann Oncol. 2016 05; 27(5):806-12.
    View in: PubMed
    Score: 0.075

© 2024 Kaiser Permanente